| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute myeloid leukemia with t(19;21)(q13;q22) and marked eosinophilia
|
Kubota, Yasushi
|
|
2018
|
98 |
1 |
p. 221-222
|
artikel
|
| 2 |
Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib
|
Wanner, David
|
|
2018
|
98 |
1 |
p. 205-207
|
artikel
|
| 3 |
Autopsy findings in patients with acute myeloid leukemia and non-Hodgkin lymphoma in the modern era: a focus on lung pathology and acute respiratory failure
|
Van de Louw, Andry
|
|
2018
|
98 |
1 |
p. 119-129
|
artikel
|
| 4 |
Burden of illness of follicular lymphoma and marginal zone lymphoma
|
Monga, Neerav
|
|
2018
|
98 |
1 |
p. 175-183
|
artikel
|
| 5 |
Cardiovascular disease in chronic myelomonocytic leukemia: do monocytosis and chronic inflammation predispose to accelerated atherosclerosis?
|
Elbæk, Mette Vestergaard
|
|
2018
|
98 |
1 |
p. 101-109
|
artikel
|
| 6 |
Classifying AML patients with inv(16) into high-risk and low-risk relapsed patients based on peritransplantation minimal residual disease determined by CBFβ/MYH11 gene expression
|
Xiaosu, Zhao
|
|
2018
|
98 |
1 |
p. 73-81
|
artikel
|
| 7 |
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study
|
Kawashima, Naomi
|
|
|
98 |
1 |
p. 83-91
|
artikel
|
| 8 |
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 study
|
Kawashima, Naomi
|
|
2018
|
98 |
1 |
p. 83-91
|
artikel
|
| 9 |
Cytogenetically cryptic insertion of PML segment into RARA on chromosome 17q resulting PML-RARA fusion in acute promyelocytic leukemia
|
Burns, Timothy F.
|
|
2018
|
98 |
1 |
p. 211-213
|
artikel
|
| 10 |
Cytotoxic T-lymphocyte-associated antigen 4-positive aggressive adult T cell leukemia/lymphoma
|
Sueda, Sanae
|
|
2018
|
98 |
1 |
p. 235-236
|
artikel
|
| 11 |
Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies
|
Gao, Xiao-Ning
|
|
2018
|
98 |
1 |
p. 185-193
|
artikel
|
| 12 |
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party
|
Jung, Sung-Hoon
|
|
2018
|
98 |
1 |
p. 151-158
|
artikel
|
| 13 |
Gemcitabine, cisplatin, and dexamethasone (GDP) in combination with methotrexate and pegaspargase is active in newly diagnosed peripheral T cell lymphoma patients: a phase 2, single-center, open-label study in China
|
Zhang, Yan
|
|
2018
|
98 |
1 |
p. 143-150
|
artikel
|
| 14 |
Glucocorticoids in multiple myeloma: past, present, and future
|
Burwick, Nicholas
|
|
2018
|
98 |
1 |
p. 19-28
|
artikel
|
| 15 |
Hemophagocytic syndrome in patients living with HIV: a retrospective study
|
Telles, João Paulo
|
|
2018
|
98 |
1 |
p. 67-72
|
artikel
|
| 16 |
High risk of recurrent venous thromboembolism in BCR-ABL-negative myeloproliferative neoplasms after termination of anticoagulation
|
Wille, Kai
|
|
2018
|
98 |
1 |
p. 93-100
|
artikel
|
| 17 |
Immunosuppressive therapy for aplastic anemia: a single-center experience from western India
|
Shah, Sandip
|
|
2018
|
98 |
1 |
p. 41-46
|
artikel
|
| 18 |
Incidence and treatment outcome of aplastic anemia in Taiwan—real-world data from single-institute experience and a nationwide population-based database
|
Li, Sin-Syue
|
|
2018
|
98 |
1 |
p. 29-39
|
artikel
|
| 19 |
Intensive care unit admission in patients with T cell lymphomas: clinical features and outcome
|
Dumas, Guillaume
|
|
2018
|
98 |
1 |
p. 195-203
|
artikel
|
| 20 |
Langerhans cell histiocytosis associated with classical Hodgkin lymphoma contains BRAF V600E mutation
|
Zhang, Shanxiang
|
|
2018
|
98 |
1 |
p. 231-233
|
artikel
|
| 21 |
Long-term follow-up of a single institution pilot study of sirolimus, tacrolimus, and short course methotrexate for graft versus host disease prophylaxis in mismatched unrelated donor allogeneic stem cell transplantation
|
Kim, Tae Kon
|
|
2018
|
98 |
1 |
p. 237-240
|
artikel
|
| 22 |
Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient
|
Hinterleitner, Clemens
|
|
2018
|
98 |
1 |
p. 227-230
|
artikel
|
| 23 |
Major bleeding in a patient with warfarin-hypersensitive and factor IX propeptide variant, p.Ala37Thr, who was treated with a direct oral anti-Xa inhibitor
|
Tamura, Asako
|
|
2018
|
98 |
1 |
p. 209-210
|
artikel
|
| 24 |
Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma
|
Maruyama, Dai
|
|
2018
|
98 |
1 |
p. 131-142
|
artikel
|
| 25 |
MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type
|
Nosrati, Anahita
|
|
2018
|
98 |
1 |
p. 169-173
|
artikel
|
| 26 |
National registry of hemoglobinopathies in Greece: updated demographics, current trends in affected births, and causes of mortality
|
Voskaridou, Ersi
|
|
2018
|
98 |
1 |
p. 55-66
|
artikel
|
| 27 |
Navigating the treatment landscape in multiple myeloma: which combinations to use and when?
|
Goldschmidt, Hartmut
|
|
2018
|
98 |
1 |
p. 1-18
|
artikel
|
| 28 |
Neurologic adverse events in patients with relapsed/refractory acute lymphoblastic leukemia treated with blinatumomab: management and mitigating factors
|
Stein, Anthony S.
|
|
2018
|
98 |
1 |
p. 159-167
|
artikel
|
| 29 |
Newborn screening by tandem mass spectrometry confirms the high prevalence of sickle cell disease among German newborns
|
Lobitz, Stephan
|
|
2018
|
98 |
1 |
p. 47-53
|
artikel
|
| 30 |
Next-generation sequencing for JAK2 mutation testing: advantages and pitfalls
|
Maslah, Nabih
|
|
2018
|
98 |
1 |
p. 111-118
|
artikel
|
| 31 |
Next-generation sequencing identified a novel SPTB frameshift insertion causing hereditary spherocytosis in China
|
Meng, Lan-Lan
|
|
2018
|
98 |
1 |
p. 223-226
|
artikel
|
| 32 |
Risk of viral reactivation in patients with occult hepatitis B virus infection during ruxolitinib treatment
|
Gill, Harinder
|
|
2018
|
98 |
1 |
p. 215-218
|
artikel
|
| 33 |
γδ T cell clonal proliferation early after PD-1 blockade
|
Ono, Koya
|
|
2018
|
98 |
1 |
p. 219-220
|
artikel
|
Tijdschrift beschrijving